NVAX: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/bb2bc780-6b4d-480c-96ab-d4b1a4804c22/","filing_uuid":"bb2bc780-6b4d-480c-96ab-d4b1a4804c22","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/bb2bc780-6b4d-480c-96ab-d4b1a4804c22/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Moschella, Attorney at Law","dt_posted":"2026-07-16T18:25:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"600 Massachusetts Ave, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7257,"url":"https://lda.gov/api/v1/registrants/7257/","house_registrant_id":31842,"name":"BROWNSTEIN HYATT FARBER SCHRECK, LLP","description":"Law firm","address_1":"600 Massachusetts Ave, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"QUINN MCKAY","contact_telephone":"+1 202-872-5292","dt_updated":"2026-07-30T12:03:37.302760-04:00"},"client":{"id":68681,"url":"https://lda.gov/api/v1/clients/68681/","client_id":68681,"name":"NOVAVAX, INC.","general_description":"Biotechnology company","client_government_entity":null,"client_self_select":false,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-08-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151302,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151344,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"GERARD","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151266,"prefix":null,"prefix_display":null,"first_name":"TIM","nickname":null,"middle_name":null,"last_name":"SHADYAC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151303,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}